Display options
Share it on

Ann Transl Med. 2018 Jun;6(12):245. doi: 10.21037/atm.2018.04.09.

Molecular mechanisms of mechanotransduction in psoriasis.

Annals of translational medicine

Lina S Malakou, Antonios N Gargalionis, Christina Piperi, Evangelia Papadavid, Athanasios G Papavassiliou, Efthimia K Basdra

Affiliations

  1. Cellular and Molecular Biomechanics Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  2. Second Department of Dermatology, Medical School, National and Kapodistrian University of Athens, 'Attikon' General University Hospital, Athens, Greece.

PMID: 30069447 PMCID: PMC6046295 DOI: 10.21037/atm.2018.04.09

Abstract

Psoriasis is an immune disease of the skin that frequently develops upon triggering events of mechanical nature and leads to increased proliferation and damaged differentiation of keratinocytes of the epidermis. Mechanical forces are mediated through mechanotransduction, which is the process that translates physical cues into biochemical signaling networks. Latest updates underline the role of mechanotransduction during the acquisition of aberrant properties by the keratinocytes of the skin, therefore implying a potential contribution that promotes psoriasis pathogenesis. The present review discusses the mechano-induced signaling pathways and individual molecules that become activated in psoriasis and in keratinocytes, along with mechano-based putative treatment strategies. We also suggest emerging mechanosensitive molecules for further investigation with potential diagnostic and therapeutic utility in psoriasis.

Keywords: Mechanotransduction; TRP channels; Yes-associated/TAZ (YAP/TAZ); polycystin; psoriasis

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. J Immunol. 1993 Mar 15;150(6):2148-59 - PubMed
  2. J Exp Med. 2006 Nov 27;203(12):2577-87 - PubMed
  3. Nat Rev Neurosci. 2001 Jun;2(6):387-96 - PubMed
  4. Cell. 2001 Jan 12;104(1):9-19 - PubMed
  5. J Exp Med. 2004 Mar 1;199(5):731-6 - PubMed
  6. J Cell Physiol. 2002 Jul;192(1):45-54 - PubMed
  7. Clin Dermatol. 2011 Mar-Apr;29(2):231-6 - PubMed
  8. Int J Dermatol. 1982 May;21(4):192-7 - PubMed
  9. Cell Mol Life Sci. 2017 Mar;74(5):921-936 - PubMed
  10. Curr Biol. 2007 Dec 4;17(23):2054-60 - PubMed
  11. J Dermatol Sci. 2010 Aug;59(2):73-80 - PubMed
  12. J Invest Dermatol. 2010 Jul;130(7):1945-8 - PubMed
  13. Am J Physiol Cell Physiol. 2006 Jul;291(1):C185-8 - PubMed
  14. J Am Acad Dermatol. 2009 Mar;60(3):394-401 - PubMed
  15. Mol Biol Rep. 1996;23(1):59-70 - PubMed
  16. Clin Rev Allergy Immunol. 2007 Oct;33(1-2):45-56 - PubMed
  17. Acta Derm Venereol. 2014 Jul;94(4):371-9 - PubMed
  18. Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2270-5 - PubMed
  19. Nat Commun. 2017 May 17;8:15206 - PubMed
  20. J Biol Chem. 2008 Dec 5;283(49):33942-54 - PubMed
  21. Genes Dev. 2006 Nov 1;20(21):3022-35 - PubMed
  22. Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2569-74 - PubMed
  23. Nature. 1993 Sep 30;365(6445):388-9 - PubMed
  24. Postepy Dermatol Alergol. 2017 Oct;34(5):405-417 - PubMed
  25. J Invest Dermatol. 2014 Feb;134(2):518-525 - PubMed
  26. J Cell Biol. 1998 Jun 15;141(6):1449-65 - PubMed
  27. Cytokine. 2015 Jun;73(2):342-50 - PubMed
  28. Immunity. 2004 Aug;21(2):241-54 - PubMed
  29. Ann Dermatol Venereol. 2011 Dec;138 Suppl 4:S233-40 - PubMed
  30. Arch Dermatol Res. 2002 Nov;294(8):363-9 - PubMed
  31. CMAJ. 2013 Apr 16;185(7):585 - PubMed
  32. J Invest Dermatol. 2013 Jun;133(6):1497-505 - PubMed
  33. Trends Mol Med. 2016 Jan;22(1):7-9 - PubMed
  34. Curr Pharm Biotechnol. 2009 Apr;10(3):302-10 - PubMed
  35. J Cell Sci. 2014 Oct 15;127(Pt 20):4343-50 - PubMed
  36. J Cell Biochem. 2018 Jun;119(6):4304-4308 - PubMed
  37. Dermatol Clin. 2015 Jan;33(1):1-11 - PubMed
  38. Clin Rev Allergy Immunol. 2018 Feb;54(1):102-113 - PubMed
  39. Br J Dermatol. 2013 Jul;169(1):156-9 - PubMed
  40. Cell Mol Immunol. 2012 Jul;9(4):302-9 - PubMed
  41. Arthritis Res Ther. 2008;10(1):201 - PubMed
  42. Science. 1987 Jan 16;235(4786):350-2 - PubMed
  43. Pflugers Arch. 2012 Apr;463(5):715-25 - PubMed
  44. Genes Immun. 2004 Dec;5(8):662-7 - PubMed
  45. Nat Cell Biol. 2004 Aug;6(8):709-20 - PubMed
  46. Int J Cancer. 2018 Apr 1;142(7):1298-1299 - PubMed
  47. Br J Dermatol. 1989 Jan;120(1):1-8 - PubMed
  48. Biol Cell. 2018 Mar;110(3):49-64 - PubMed
  49. Am J Pathol. 2005 Jul;167(1):59-69 - PubMed
  50. J Dermatol. 2018 Mar;45(3):264-272 - PubMed
  51. J Invest Dermatol. 2002 Nov;119(5):1128-36 - PubMed
  52. Compr Physiol. 2013 Jan;3(1):221-42 - PubMed
  53. J Exp Med. 1996 Oct 1;184(4):1413-24 - PubMed
  54. Mol Cell Biol. 2005 Feb;25(3):969-78 - PubMed
  55. Int J Mol Sci. 2017 Dec 11;18(12):null - PubMed
  56. Nat Rev Immunol. 2011 Aug 19;11(9):584-96 - PubMed
  57. Science. 1989 Feb 10;243(4892):811-4 - PubMed
  58. Oncogene. 2001 Apr 30;20(19):2413-23 - PubMed
  59. Biochem J. 2004 Jun 1;380(Pt 2):329-38 - PubMed
  60. J Invest Dermatol. 2013 Feb;133(2):377-85 - PubMed
  61. Nature. 2007 May 31;447(7144):592-5 - PubMed
  62. Cancer Cell. 2011 Jun 14;19(6):776-91 - PubMed
  63. J Invest Dermatol. 2010 Jul;130(7):1942-5 - PubMed
  64. Br J Dermatol. 2007 Dec;157(6):1168-77 - PubMed
  65. Exp Dermatol. 2006 Dec;15(12):991-1004 - PubMed
  66. Am J Pathol. 1991 Jan;138(1):129-40 - PubMed
  67. Cell. 2011 Mar 4;144(5):782-95 - PubMed
  68. Nature. 2011 Jun 08;474(7350):179-83 - PubMed
  69. Novartis Found Symp. 2004;258:172-85; discussion 185-8, 263-6 - PubMed
  70. PLoS One. 2011 Feb 22;6(2):e14716 - PubMed
  71. Cold Spring Harb Perspect Med. 2014 Aug 01;4(8):null - PubMed
  72. Br J Dermatol. 1994 Feb;130(2):139-47 - PubMed
  73. Eur J Dermatol. 2011 Sep-Oct;21(5):660-6 - PubMed
  74. J Am Acad Dermatol. 2010 Jun;62(6):979-87 - PubMed
  75. Cell Mol Life Sci. 2015 Jun;72(11):2091-106 - PubMed
  76. J Invest Dermatol. 2011 May;131(5):1095-104 - PubMed
  77. J Autoimmun. 2010 May;34(3):J314-21 - PubMed
  78. Br J Pharmacol. 2013 Dec;170(8):1676-705 - PubMed
  79. J Clin Invest. 1992 Jun;89(6):1892-901 - PubMed
  80. Immunol Rev. 2005 Dec;208:126-40 - PubMed
  81. J Immunol. 2000 Oct 1;165(7):4076-85 - PubMed
  82. Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):null - PubMed
  83. J Invest Dermatol. 2011 Nov;131(11):2186-96 - PubMed
  84. J Autoimmun. 2017 Mar;78:29-38 - PubMed
  85. Lancet. 2015 Sep 5;386(9997):983-94 - PubMed
  86. Am J Pathol. 2009 Sep;175(3):1095-106 - PubMed
  87. J Biol Chem. 2007 Aug 3;282(31):22582-91 - PubMed
  88. Arch Dermatol Res. 2011 Mar;303(2):125-33 - PubMed
  89. Sci Rep. 2015 Aug 19;5:13461 - PubMed
  90. Ital J Anat Embryol. 2014;119(3):277-85 - PubMed
  91. Am J Pathol. 2005 Apr;166(4):985-98 - PubMed
  92. Indian J Dermatol. 2014 Jan;59(1):67-70 - PubMed
  93. Arch Dermatol. 1965 Mar;91:246-51 - PubMed
  94. Cell Adhes Commun. 1995 Nov;3(4):337-52 - PubMed
  95. Int J Dermatol. 1990 Jul-Aug;29(6):401-10 - PubMed
  96. Expert Rev Clin Immunol. 2017 Mar;13(3):207-222 - PubMed
  97. J Invest Dermatol. 2005 Jul;125(1):viii-ix; discussion x-xi - PubMed
  98. J Pharmacol Exp Ther. 2003 Jan;304(1):217-22 - PubMed
  99. Int J Cancer. 2015 Apr 1;136(7):1515-27 - PubMed
  100. Nat Rev Mol Cell Biol. 2005 Apr;6(4):328-40 - PubMed
  101. Science. 2013 Dec 6;342(6163):1226-30 - PubMed
  102. J Cell Biol. 2013 Jul 8;202(1):45-52 - PubMed
  103. J Invest Dermatol. 1992 Sep;99(3):350-6 - PubMed
  104. Cell Mol Life Sci. 2013 Jan;70(1):167-180 - PubMed
  105. Int J Mol Sci. 2018 Jan 08;19(1):null - PubMed

Publication Types